Back to Search
Start Over
Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice.
- Source :
-
Cardiovascular research [Cardiovasc Res] 2021 Sep 28; Vol. 117 (11), pp. 2354-2364. - Publication Year :
- 2021
-
Abstract
- Aims: Gp91-containing NADPH oxidases (NOX2) are a significant source of myocardial superoxide production. An increase in NOX2 activity accompanies atrial fibrillation (AF) induction and electrical remodelling in animal models and predicts incident AF in humans; however, a direct causal role for NOX2 in AF has not been demonstrated. Accordingly, we investigated whether myocardial NOX2 overexpression in mice (NOX2-Tg) is sufficient to generate a favourable substrate for AF and further assessed the effects of atorvastatin, an inhibitor of NOX2, on atrial superoxide production and AF susceptibility.<br />Methods and Results: NOX2-Tg mice showed a 2- to 2.5-fold higher atrial protein content of NOX2 compared with wild-type (WT) controls, which was associated with a significant (twofold) increase in NADPH-stimulated superoxide production (2-hydroxyethidium by HPLC) in left and right atrial tissue homogenates (P = 0.004 and P = 0.019, respectively). AF susceptibility assessed in vivo by transoesophageal atrial burst stimulation was modestly increased in NOX2-Tg compared with WT (probability of AF induction: 88% vs. 69%, respectively; P = 0.037), in the absence of significant alterations in AF duration, surface ECG parameters, and LV mass or function. Mechanistic studies did not support a role for NOX2 in promoting electrical or structural remodelling, as high-resolution optical mapping of atrial tissues showed no differences in action potential duration and conduction velocity between genotypes. In addition, we did not observe any genotype difference in markers of fibrosis and inflammation, including atrial collagen content and Col1a1, Il-1β, Il-6, and Mcp-1 mRNA. Similarly, NOX2 overexpression did not have consistent effects on RyR2 Ca2+ leak nor did it affect PKA or CaMKII-mediated RyR2 phosphorylation. Finally, treatment with atorvastatin significantly inhibited atrial superoxide production in NOX2-Tg but had no effect on AF induction in either genotype.<br />Conclusion: Together, these data indicate that while atrial NOX2 overexpression may contribute to atrial arrhythmogenesis, NOX2-derived superoxide production does not affect the electrical and structural properties of the atrial myocardium.<br /> (© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Subjects :
- Action Potentials
Animals
Anti-Arrhythmia Agents pharmacology
Atorvastatin pharmacology
Atrial Fibrillation genetics
Atrial Fibrillation physiopathology
Atrial Fibrillation prevention & control
Disease Models, Animal
Enzyme Induction
Enzyme Inhibitors pharmacology
Heart Atria drug effects
Heart Atria physiopathology
Mice, Transgenic
Myocytes, Cardiac drug effects
NADPH Oxidase 2 antagonists & inhibitors
NADPH Oxidase 2 genetics
Signal Transduction
Superoxides metabolism
Time Factors
Atrial Fibrillation enzymology
Heart Atria enzymology
Heart Rate
Myocytes, Cardiac enzymology
NADPH Oxidase 2 biosynthesis
Subjects
Details
- Language :
- English
- ISSN :
- 1755-3245
- Volume :
- 117
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Cardiovascular research
- Publication Type :
- Academic Journal
- Accession number :
- 33483749
- Full Text :
- https://doi.org/10.1093/cvr/cvab019